Načítá se...
Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC
BACKGROUND: Dendritic cells (DCs) could be used as potential cellular adjuvant for the production of specific tumor vaccines. OBJECTIVES: Our study was aimed to evaluate the safety and efficacy of autologous pulsed DC vaccine in advanced hepatocellular carcinoma (HCC) patients in comparison with sup...
Uloženo v:
| Vydáno v: | J Cancer Res Clin Oncol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5223882/ https://ncbi.nlm.nih.gov/pubmed/22886490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-012-1298-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|